Condition: Peripheral Arterial Disease · Sponsor: M.A. Med Alliance S.A.
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.
This description comes directly from the study's public registry record.
Kara Piscani · +14846805857 · kara.piscani@cordis.com
Tamarah Suys · +41788957756 · tamarah.suys@cordis.com
Always discuss trial participation with your own doctor first.
| Chandler Regional Medical Center | Chandler, Arizona, United States | Recruiting |
| St. Bernards Medical Center | Jonesboro, Arkansas, United States | Recruiting |
| Arkansas Heart Hospital | Little Rock, Arkansas, United States | Terminated |
| St. Helena Hospital | St. Helena, California, United States | Terminated |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Torrance, California, United States | Recruiting |
| ClinRé | Thornton, Colorado, United States | Terminated |
| Vascular Care Group | Darien, Connecticut, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| The Cardiac and Vascular Institute Research Foundation | Gainesville, Florida, United States | Recruiting |
| Palm Vascular Centers | Miami, Florida, United States | Recruiting |
| Guardian Research Organization, LLC | Winter Park, Florida, United States | Recruiting |
| Cardiovascular Consultants of South Georgia | Thomasville, Georgia, United States | Terminated |
+ 36 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05055297